[Tryptamine (above) is explicitly not captured by this clause]
1(b)
Any compound (not being a compound for the time being specified in sub-paragraph (a) above structurally derived from Tryptamine or from a ring-hydroxy Tryptamine by modification in any of the following ways, that is to say—
- by substitution at the nitrogen atom of the sidechain to any extent with alkyl or alkenyl substituents, or by inclusion of the nitrogen atom of the side chain (and no other atoms of the side chain) in a cyclic structure;
- by substitution at the carbon atom adjacent to the nitrogen atom of the side chain with alkyl or alkenyl substituents;
- by substitution in the 6-membered ring to any extent with alkyl, alkoxy, haloalkyl, thioalkyl, alkylenedioxy, or halide substituents;
- by substitution at the 2-position of the tryptamine ring system with an alkyl substituent
Effective 7 Jan 2015, S.I. 2014/3271 replacement for:
On 30 Oct 2014, S.I. 2014/3271** proposed replacement for:
On 16 Jul 2014, S.I. 2014/3271* proposed replacement for:
Effective 20 Sep 1977, S.I. 1977/1243 added:
Any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from Tryptamine or from a ring-hydroxy Tryptamine by substitution at the nitrogen atom of a side-chain with one or more alkyl substituents but no other substituent.
This description of a “generic” controlled tryptamine includes mono- or di-N-substitution (e.g. DPT, DIPT, NMT, NET, MET, MPT, MIPT, EIPT, etc.), and their ring hydroxy (4-HO-DET, 4-HO-DIPT, 4-HO-MIPT, 5-HO-DET, etc.) analogues.
Furthermore, paragraph 3 of this schedule extends its reach to ethers and esters of controlled substances, thereby embracing the ethers 5-MeO-DET, 5-MeO-DIPT, 5-MeO MIPT, the esters 4-Acetoxy DMT and 4-Phosphoryloxy DMT, and countless others.
Listed below are some examples of substances explicitly controlled in other jurisdictions that are members of the group implicitly controlled by this generic definition.
Please note that there are many, many substances controlled by this paragraph that are not listed below, and the absence of a substance from this tally should not be taken as an indication of legality.
5-Methoxy-N,N-diisopropyltryptamine (Methyl ether of 5-Hydroxy-N,N-diisopropyltryptamine)
US: CSA Schedule I Section d Subsection 20 5-Methoxy-N,N-diisopropyltryptamine
⇒
PubChem: 151182; ChemSpider: 133247; Bluelight: 5-MeO-DiPT; Drugs Forum: 5-MeO-DIPT; Erowid: 5-MeO-DIPT; TiHKAL • info: 5-MeO-DIPT; Wikipedia: 5-Methoxy-diisopropyltryptamine
Psilocybin (Phosphate ester of 4-Hydroxy-N,N-dimethyltryptamine)
CA: CDSA Schedule III Section 12 Psilocybin
UN: Psychotropics Schedule I Psilocybine
US: CSA Schedule I Section d Subsection 29 Psilocybin
⇒
PubChem: 10624; ChemSpider: 10178; Drugs Forum: 4-H2PO4-DMT; Erowid: Psilocybin & Psilocin; TiHKAL • info: 4-H2PO4-DMT; Wikipedia: Psilocybin
11 March 2016 · 
· Isomer Design
· Isomer Design